Current Report Filing (8-k)
June 07 2021 - 11:45AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event
reported): June 7, 2021
______________
MERA PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
______________
Delaware
|
|
333-23460
|
|
04-3683628
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
8275 S. Easter Ave. Suite 200, Las Vegas, NV 89123
(Address of principal executive offices) (Zip Code)
917-215-0680
Registrant’s telephone number, including area
code
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions ( see General
Instruction A.2. below):
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Item 3.03 Material Modification to Rights of Security
Holders.
The
Company is doing a rights offering to its shareholders. The
offering is available to shareholders of record as of June 16,
2021. Under this non-dilutive offering, each shareholder has the
right to purchase additional shares in proportion to the number of
currently held shares at a price of $0.25 per share. Interested
shareholders are invited to join the company on a conference call
on Friday, June 11, 2021 at 6 pm PST. To register for access to the
conference please email your name and shareholdings to ir@allyourfoods.com.
Questions to be asked during the call must be submitted via email
at least 24 hours before the call. The rights offering will remain
open to all shareholders of record as of June 16, 2021 until
December 31, 2021.
On
March 22, 2021, the Company entered into a share exchange agreement
under which the Company acquired 100 percent of the outstanding
interests of All Your Foods USA, Inc in exchange for 35,200,000
common shares of the Company.
All
Your Foods USA INC
All
Your Foods USA via its brands
Chopandchisel.com
Cavemanchefs.com
Allyourmeals.com
allyourfoods.com
Delivering healthy,
gourmet ready-made meals, prepared and delivered to the client's
door. Our corporate chefs work hard to design meals that are
nutritionally balanced with no preservatives, freshly made and
designed to optimize customer's health and serve their busy
lifestyle. The Company’s meals menu includes entrees and
breakfasts with dairy products, eggs, pork, tree nuts, chicken,
beef, turkey, fish, soy, shellfish as well as an all-Vegan line of
dishes. All Your Foods offers Ala La Carte and weekly
subscriptions.
All
Your Foods production kitchens are also used to supply white label
products to other successful national subscriptions brands in both
the USA and Canada. The technology at the heart of the All Your
Foods USA systems, is what allows the unlimited scaling of client
and corporate orders of meals and other food products.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
Mera Pharmaceuticals, Inc.
|
|
|
|
|
|
Dated:
June 7, 2021
|
By:
|
/s/ Benny
Doro
|
|
|
Name:
|
Benny
Doro
|
|
|
Title:
|
Chief
Executive Officer and President
|
|
Exhibits
Mera Pharmaceuticals (CE) (USOTC:MRPI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Mera Pharmaceuticals (CE) (USOTC:MRPI)
Historical Stock Chart
From Jan 2024 to Jan 2025